Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10881443 | 0.85 | CYP2D6 (0.47) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL10881451 | 0.85 | CYP2D6 (0.47) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL27632932 | 0.83 | MAPT (0.53) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL9741642 | 0.80 | MAPT (0.46) | KMT2AMAPTCYP2D6CYP1A2KCNN4 | |
| SCHEMBL29084050 | 0.80 | MAPT (0.50) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL4560696 | 0.79 | MAPT (0.53) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL615869 | 0.79 | MAPT (0.48) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL14246913 | 0.78 | KMT2A (0.47) | KMT2AMAPTCYP2D6CYP1A2ALOX5 | |
| SCHEMBL3838081 | 0.77 | KIF11 (0.49) | KMT2AMAPTCYP2D6CYP1A2LMNA | |
| SCHEMBL616397 | 0.77 | MAPT (0.47) | KMT2AMAPTCYP2D6CYP1A2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198244-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2021-07-01 | — | — | US | disclosed |
| US-10745390-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-08-18 | — | — | US | disclosed |
| US-20170334890-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-11-23 | — | — | US | disclosed |
| US-9695157-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-07-04 | — | — | US | disclosed |
| US-20150210674-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-07-30 | — | — | US | disclosed |
| US-9000009-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-04-07 | — | — | US | disclosed |
| US-20120041023-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| WO-2010068767-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210674-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KMT2A 3433/4885MAPT 564/4885CYP2D6 3839/4885 |
| US-20170334890-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KMT2A 3433/4885MAPT 564/4885CYP2D6 3839/4885 |
| US-20120041023-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KMT2A 3504/4885MAPT 589/4885CYP2D6 3614/4885 |
| US-10745390-B2 | Small molecule activators of mitochondrial function | TFAM, TFB2M, GFM1 | KMT2A 3433/4885MAPT 564/4885CYP2D6 3839/4885 |
| US-20210198244-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KMT2A 3433/4885MAPT 564/4885CYP2D6 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.